Markowska, J.; Kasprzak-Drozd, K.; Niziński, P.; Dragan, M.; Kondracka, A.; Gondek, E.; Oniszczuk, T.; Oniszczuk, A.
Quercetin: A Promising Candidate for the Management of Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD). Molecules 2024, 29, 5245.
https://doi.org/10.3390/molecules29225245
AMA Style
Markowska J, Kasprzak-Drozd K, Niziński P, Dragan M, Kondracka A, Gondek E, Oniszczuk T, Oniszczuk A.
Quercetin: A Promising Candidate for the Management of Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD). Molecules. 2024; 29(22):5245.
https://doi.org/10.3390/molecules29225245
Chicago/Turabian Style
Markowska, Julia, Kamila Kasprzak-Drozd, Przemysław Niziński, Magdalena Dragan, Adrianna Kondracka, Ewa Gondek, Tomasz Oniszczuk, and Anna Oniszczuk.
2024. "Quercetin: A Promising Candidate for the Management of Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)" Molecules 29, no. 22: 5245.
https://doi.org/10.3390/molecules29225245
APA Style
Markowska, J., Kasprzak-Drozd, K., Niziński, P., Dragan, M., Kondracka, A., Gondek, E., Oniszczuk, T., & Oniszczuk, A.
(2024). Quercetin: A Promising Candidate for the Management of Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD). Molecules, 29(22), 5245.
https://doi.org/10.3390/molecules29225245
